Real-World Efficacy Of Ribociclib Plus Aromatase Inhibitor/Fulvestrant, Or Endocrine Monotherapy, Or Chemotherapy As First-Line Treatment In Women With Hr-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer: Third Interim Analysis From The Ribanna Study